Paracoccidioidomycosis: Survey and clinical aspects from the Department of Dermatology of the School of Medicine of Botucatu (Sao Paulo - Brazil)
Nenhuma Miniatura disponível
Data
1998-09-01
Autores
Marques, Silvio Alencar [UNESP]
Dillon, Neuza Lima
Camargo, Rosangela M. P.
Habermann, Marta Cassoni
Lastoria, Joel Carlos [UNESP]
Barraviera, Silvia Regina Catharino Sartori [UNESP]
Bretan, Onivaldo [UNESP]
Marques, Mariângela Esther Alencar [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Background - Paracoccidioidomycosis is the most frequent among the systemic mycoses in Brazil. Objective: To study the cases of paracoccidioidomycosis diagnosed from 1976 to 1996 at the Department of Dermatology of the School of Medicine of Botucatu. Methods - Descriptive study obtained from specific protocols comprising anamnesis, clinical- dermatological-laboratorial examination, treatment and follow-up of the patients. Results - Paracoccidioidomycosis was diagnosed in 1.04% of the dermatologic outpatients assisted from 1976 to 1996. In 315 cases, 89.8% were male, 61.9% were over forty and 53.7% were rural workers. The complaints were related more to oropharyngolaryngeal (53.6%) or cutaneous (23.8%) lesions or adenopathy (10.2%). Seventy patients had already been treated in other health services. The chronic multifocal clinical from was the most common: 80.6% of the cases, followed by the acute-subacute (juvenile type) 15.5%. The disease was pulmonary in 80.0%, oropharyngolaryngeal in 69.2% and cutaneous in 45.7%. Th treatment: Amphotericin B in 146 patients, Ketoconazole - 88, Itraconazole - 56, Sulfonamide derivatives - 146 and Terbinafine in 3. The lethality index resulting from the disease or its treatment was 2.0%. Conclusions - The high number of cases, showing the regional relevance of the disease and the high percentage of tegumentary complaints and the high number of relapsing are remarkable.
Descrição
Palavras-chave
Epidemiology, Mycoses, Paracoccidioidomycosis, amphotericin b, itraconazole, ketoconazole, sulfonamide, terbinafine, adult, antifungal activity, Brazil, clinical protocol, female, human, major clinical study, male, relapse, south american blastomycosis, treatment outcome
Como citar
Anais Brasileiros de Dermatologia, v. 73, n. 5, p. 411-417, 1998.